Akso Health Group

NASDAQ:AHG

Financial - Credit Services

Financial Services
$1.36 +2.44%

+$0.03 today

Market cap
$1.16B
Beta
-1.02
P/E (TTM)
-3.1
EPS (TTM)
-$0.40
52W Low $1.07High $2.50

Volume 0.00M

Average 0.12M

AHG Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Akso Health GroupNASDAQ: AHG

Accounts Receivables · Q4 FY2025 · quarter ended Mar 2025

Accounts receivables turns negative

Q4 FY2025 accounts receivables was -$250.65K, compared with $0 a year earlier. Trailing-twelve-month accounts receivables was -$859.54K.

Context

  • Accounts receivables amounted to 5.8% of revenue in FY2025, down 7.7 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly accounts receivables holds near -$250.65K or moves back toward the trailing-twelve-month quarterly average of -$214.89K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2025
-$250.65K+0.0% QoQ
Last fiscal yearMar 2025
-$859.54K-362.7% YoY
LTMMar 2025
-$859.54K-362.7% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-362.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(859.54K) USD
Year-over-year change
-362.7%

Accounts Receivables vs competitors

How AHG compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -362.7% is the 3rd highest of 4, against a peer median of +100.0%.
  • Accounts receivables amounts to 5.8% of revenue for AHG, versus a peer median of 1.7%.
AHG Competitors
Accounts Receivables for AHG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MOMOHello Group Inc.LTM Mar 2026CN¥176M CNY-3813.8%—1.7%
JMIAJumia Technologies AGLTM Mar 2026$11.03M USD+1214.2%—5.4%
AHGAkso Health GroupLTM Mar 2025$859.54K USD-362.7%—5.8%
ZKHZKH Group LimitedLTM Jun 2025CN¥0 CNY+100.0%-32.4%0.0%
Peer median (excluding AHG) —+100.0%-32.4%1.7%

Competitors are the stored peer set for AHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Mar 2021
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
Net Income(34.72M)(16.85M)(13.08M)(9.12M)(135.47M)
Depreciation & Amortization15.16K18.39K002.15M
Deferred Income Tax26.76M000(30.8M)
Stock-Based Compensation55.47K391.63K000
Change in Working Capital21.11M(2.56M)(1.17M)2.06M3.02M
Accounts Receivables(25.43K)13.89K(8.1M)327.19K(859.54K)
Inventory20.52M(7.8M)6.11M1.5M0
Accounts Payables(82.1K)(104.24K)712.89K166.05K417.18K
Other Working Capital700.15K76.29K102.42K67.96K3.46M
Other Non-Cash Items(3.16M)10.38M11M8.41M162.28M
Operating Cash Flow10.06M(8.63M)(3.25M)1.35M1.18M
Capital Expenditures0(4.86K)00(154.46K)
Acquisitions (Net)0000(93.75M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(662)(19.96M)18.47M(54.72M)(12.01M)
Investing Cash Flow(662)(19.96M)18.47M(54.72M)(105.91M)
Debt Repayment(10M)(10M)(27.51M)(7.69M)0
Common Stock Issued510.02M0139.34M195.88M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities962.77K34.76M000
Financing Cash Flow(9.04M)34.78M(27.51M)131.65M195.88M
Effect of Forex Changes3.18M607.72K(436.51K)(1.27M)(1.12M)
Net Change in Cash4.2M6.8M(12.73M)77.01M90.03M
Free Cash Flow10.06M(8.63M)(3.25M)1.35M1.02M

Akso Health Group

NASDAQ:AHG

Intrinsic Alpha fair value

Locked

Current Price

$1.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.